| # | Drug | Count |
|---|---|---|
| 0 | DOXORUBICIN | 61 |
| 1 | FLUOROURACIL | 57 |
| 2 | FLUOROURACIL CREAM, 0.5% | 57 |
| 3 | OXALIPLATIN | 55 |
| 4 | CARBOPLATIN | 50 |
| 5 | CYCLOPHOSPHAMIDE | 47 |
| 6 | CYCLOPHOSPHAMIDE FOR INJECTION | 47 |
| 7 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 47 |
| 8 | SODIUM CHLORIDE | 46 |
| 9 | ACETAMINOPHEN | 44 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM TETRADECYL SULFATE | 1 | 0.0182 |
| 1 | LEUCINE, PHENYLALANINE, LYSINE, METHIONINE, ISOLEUCINE, VALINE, HISTIDINE, THREONINE, TRYPTOPHAN, ALANINE, GLYCINE, ARGININE, PROLINE, SERINE, TYROSINE, DEXTROSE | 1 | 0.0152 |
| 2 | LEUCINE, PHENYLALANINE, LYSINE, METHIONINE, ISOLEUCINE, VALINE, HISTIDINE, THREONINE, TRYPTOPHAN, ALANINE, GLYCINE, ARGININE, PROLINE, SERINE, TYROSINE, DIBASIC POTASSIUM PHOSPHATE, MAGNESIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE, DEXTROSE | 1 | 0.0127 |
| 3 | METYROSINE | 1 | 0.0123 |
| 4 | DIMETHYL SULFOXIDE | 3 | 0.0123 |
| 5 | MITOMYCIN | 38 | 0.0104 |
| 6 | PROPOFOL INJECTABLE EMULSION | 1 | 0.0090 |
| 7 | REMIMAZOLAM BESYLATE | 1 | 0.0090 |
| 8 | ESMOLOL HYDROCHLORIDE | 2 | 0.0075 |
| 9 | HEMIN | 4 | 0.0067 |
| # | Drug class | Count |
|---|---|---|
| 0 | Platinum-based Drug [EPC] | 113 |
| 1 | Corticosteroid [EPC] | 76 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 75 |
| 3 | Alkylating Drug [EPC] | 64 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 55 |
| 5 | Microtubule Inhibitor [EPC] | 53 |
| 6 | Osmotic Laxative [EPC] | 52 |
| 7 | Catecholamine [EPC] | 37 |
| 8 | alpha-Adrenergic Agonist [EPC] | 34 |
| 9 | beta-Adrenergic Agonist [EPC] | 34 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Catecholamine Synthesis Inhibitor [EPC] | 1 | 0.0123 |
| 1 | Sclerosing Agent [EPC] | 2 | 0.0044 |
| 2 | CD123 Interaction [EPC] | 1 | 0.0019 |
| 3 | Non-Standardized Pollen Allergenic Extract [EPC] | 1 | 0.0016 |
| 4 | Standardized Pollen Allergenic Extract [EPC] | 1 | 0.0016 |
| 5 | Adenosine Receptor Agonist [EPC] | 8 | 0.0011 |
| 6 | Macrolide Antibacterial [EPC] | 1 | 0.0010 |
| 7 | Methylating Agent [EPC] | 1 | 0.0010 |
| 8 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 9 | 0.0007 |
| 9 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 9 | 0.0007 |